Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Abdallah CG, et al. Among authors: ranganathan m. Neuropsychopharmacology. 2022 Jul;47(8):1583-1584. doi: 10.1038/s41386-022-01339-9. Neuropsychopharmacology. 2022. PMID: 35545665 Free PMC article. No abstract available.
The effects of cannabinoids on serum cortisol and prolactin in humans.
Ranganathan M, Braley G, Pittman B, Cooper T, Perry E, Krystal J, D'Souza DC. Ranganathan M, et al. Psychopharmacology (Berl). 2009 May;203(4):737-44. doi: 10.1007/s00213-008-1422-2. Epub 2008 Dec 16. Psychopharmacology (Berl). 2009. PMID: 19083209 Free PMC article.
Cannabinoids and psychosis.
Sewell RA, Ranganathan M, D'Souza DC. Sewell RA, et al. Among authors: ranganathan m. Int Rev Psychiatry. 2009 Apr;21(2):152-62. doi: 10.1080/09540260902782802. Int Rev Psychiatry. 2009. PMID: 19367509 Review.
Cannabis and psychosis/schizophrenia: human studies.
D'Souza DC, Sewell RA, Ranganathan M. D'Souza DC, et al. Among authors: ranganathan m. Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):413-31. doi: 10.1007/s00406-009-0024-2. Epub 2009 Jul 16. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 19609589 Free PMC article. Review.
The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.
Carbuto M, Sewell RA, Williams A, Forselius-Bielen K, Braley G, Elander J, Pittman B, Schnakenberg A, Bhakta S, Perry E, Ranganathan M, D'Souza DC; Yale THC Study Group. Carbuto M, et al. Among authors: ranganathan m. Psychopharmacology (Berl). 2012 Feb;219(3):885-96. doi: 10.1007/s00213-011-2417-y. Epub 2011 Aug 16. Psychopharmacology (Berl). 2012. PMID: 21845389
Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
D'Souza DC, Singh N, Elander J, Carbuto M, Pittman B, Udo de Haes J, Sjogren M, Peeters P, Ranganathan M, Schipper J. D'Souza DC, et al. Among authors: ranganathan m. Neuropsychopharmacology. 2012 Mar;37(4):1036-46. doi: 10.1038/npp.2011.295. Epub 2011 Nov 23. Neuropsychopharmacology. 2012. PMID: 22113087 Free PMC article. Clinical Trial.
206 results